Skip to main content

and
  1. Article

    Open Access

    Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease

    Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst formation that ultimately leads to kidney failure in most patients. Approximately 10% of patients who receive kidney re...

    Thomas Bais, Ron T. Gansevoort, Esther Meijer in Drugs (2022)